Skip to main content

June 2025

INST Special Walk in Drive for Ph.D. August 2025 session for reserved candidates

M. Sc. or M. Pharm. or M. Tech. in Basic or Applied Sciences, Engineering or related areas. Students who have appeared for the final year, semester examinations are also eligible, provided that the degree will be granted by the time of joining.
Opportunity for Degree Professional Course at ACTREC
Graduate, Post Graduate Degree Professional Course selected through national level examination conducted by Central Government or the agencies ICMR, DBT, DAE, DST, IIT, IISER, NISER, IISc etc. qualified.
CSMCRI Openings for Project Associate and Assistant
M.Sc in Botany / Biotechnology / Marine Biology / Marine Science / Microbiology / Bio-chemistry / Oceanography / Chemistry.
Openings for Medical Representative at Cadila Pharmaceuticals - All over India
Promote pharma product portfolio to healthcare professionals and institutions. Develop and maintain strong relationships with doctors, pharmacists, and key opinion leaders.
Openings in Production Department at Anthea Pharma - B.Pharm, MSc, BSc Apply
Having injectable experience in Shop floor Supervising activities Component preparation, Aseptic filling, Compounding Operations, Autoclave Operations, Vial Filling/Sealing, Washing, Line Chemist and Executive.
Sanofi looking for Associate Project Manager - Pharma or Life science degree Apply
Degree in a Medical, Pharma, scientific discipline or a related Life science degree, with substantial project management or clinical trials and drug development experience.
Work as Regional Medical Lead at Novartis
Lead the development and execution of local medical strategies aligned with global and franchise objectives. Identify strategic drivers and shape the patient journey and stakeholder engagement plans.
“Hidden Healers”: IASST Researchers Reveal Medicinal Promise in Poisonous Plants

Deep within Assam’s vibrant ecosystem, scientists at the Institute of Advanced Study in Science & Technology (IASST), Guwahati, have uncovered a remarkable paradox: some of nature’s most toxic flora may hold potent therapeutic potential. This revelation, emerging from extensive research into poisonous plant species, could herald a paradigm shift in natural product–based medicine.

Emcure Pharmaceuticals to Fully Acquire Zuventus Healthcare
Emcure Pharmaceuticals has announced that its Board of Directors has approved a proposal to acquire the remaining 20.42% minority stake in its subsidiary, Zuventus Healthcare Ltd. The acquisition will result in Zuventus becoming a wholly owned subsidiary of Emcure.
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials
Eli Lilly and Company announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy of investigational once-weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes